Coexpression of erythropoietin and erythropoietin receptor in Von Hippel-Lindau disease - Associated renal cysts and renal cell carcinoma

Clinical Cancer Research

Volumn 11, Issue 3, 2005, Pages 1059-1064

  Lee, Youn Soo ^a   Vortmeyer, Alexander O ^a   Lubensky, Irina A ^a   Vogel, Timothy W A ^a   Ikejiri, Barbara ^a   Ferlicot, Sophie ^c   Benoît, Gérard ^d   Giraud, Sophie ^e,g   Oldfield, Edward H ^a   Linehan, W Marston ^b   Teh, Bin T ^f   Richard, Stéphane ^d,e,f   Zhuang, Zhengping ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b Laboratoire de Pathologie   (France)

^c Service d'Urologie   (France)

^d PSL RESEARCH UNIVERSITY   (France)

^e NATIONAL CANCER INSTITUTE   (United States)

^f VAN ANDEL RESEARCH INSTITUTE   (United States)

^g BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMATURITY; KIDNEY CARCINOMA; KIDNEY CYST; MALE; MESENCHYME; MULTIPLE CANCER; PRECURSOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; VON HIPPEL LINDAU DISEASE;

BLOTTING, WESTERN; CARCINOMA, RENAL CELL; ERYTHROPOIETIN; FEMALE; GENE EXPRESSION; HIPPEL-LINDAU DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES, CYSTIC; KIDNEY NEOPLASMS; MALE; RECEPTORS, ERYTHROPOIETIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM;

EID: 19944432163     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Lamiell J, Salazar F, Hsia Y. Von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine 1989;68:1-29.
2. Knudson AG Jr. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 1985;45:1437-43.
3. Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993;260:1317-20.
4. Kim W, Kaelin WG. The von Hippel-Lindau tumor suppressor protein: new insights into oxygen sensing and cancer. Curr Opin Genet Dev 2003;13:55-60.
5. Maxwell PH. Oxygen homeostasis and cancer: insights from a rare disease. Clin Med 2002;2:356-62.
6. Choyke P, Glenn G, Walther M, et al. The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients. AJR Am J Roentgenol 1992;159:1229-34.
7. Solomon D, Schwartz A. Renal pathology in von Hippel-Lindau disease. Hum Pathol 1988;19:1072-9.
8. Lubensky IA, Gnarra JR, Bertheau P, Walther MM, Linehan WM, Zhuang Z. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients. Am J Pathol 1996;149:2089-94.
9. Vortmeyer AO, Frank S, Jeong S, et al. Developmental arrest of angioblastic lineage initiates tumorigenesis in von Hippel-Lindau disease. Cancer Res 2003;63:7051-5.
10. Stein AA, Schilp AO, Whitfield RD. The histogenesis of hemangioblastoma of the brain. J Neurosurg 1960;17:751-61.
11. Lindau A. Discussion on vascular tumors of the brain and spinal cord. Proc R Soc Med 1931;24:363-70.
12. Jakobiec FA, Font RL, Johnson FB. Angiomatosis retinae. An ultrastructural study and lipid analysis. Cancer 1976;38:2042-56.
13. Jurco S, Nadji M, Harvey DG, Parker JC Jr, Font RL, Morales AR. Hemangioblastomas: histogenesis of the stromal cell studied by immunocytochemistry. Hum Pathol 1982;13:13-18.
14. Frank TS, Trojanowski JQ, Roberts SA, Brooks JJ. A detailed immunohistochemical analysis of cerebellar hemangioblastoma: an undifferentiated mesenchymal tumor. Mod Pathol 1989;2:638-51.
15. Tanimura A, Nakamura Y, Hachisuka H, Tanimura Y, Fukumura A. Hemangioblastoma of the central nervous system: nature of the stromal cells as studied by the immunoperoxidase technique. Hum Pathol 1984;15:866-9.
16. Murphy WM, Beckwith JB, Farrow GM. Tumors of the kidney, bladder, and related urinary structures. Atlas of tumor pathology, 3rd series. Fascicle 11. Washington (DC): Armed Forces Institute of Pathology; 1994. 263 pp.
17. Gondos B. Diagnosis of tumors of the kidney: ultrastructural classification. Ann Clin Lab Sci 1981;11:308-15.
18. Yoshida SO, Imam A, Olson CA, Taylor CR. Proximal renal tubular surface membrane antigens identified in primary and metastatic renal cell carcinomas. Arch Pathol Lab Med 1986;110:825-32.
19. Lee R, Kertesz N, Joseph SB, Jegalian A, Wu H. Erythropoietin (Epo) and EpoR expression and 2 waves of erythropoiesis. Blood 2001;98:1408-15.
20. Maxwell PH, Ratcliffe PJ. Oxygen sensors and angiogenesis. Semin Cell Dev Biol 2002;13:29-37.
21. Vortmeyer AO, Weil RJ, Zhuang Z. Proteomic applications for differential diagnosis of histologically identical tumors. Neurology 2003;61:1626-7.
22. Westenfelder C. Unexpected renal actions of erythropoietin. Exp Nephrol 2002;10:294-8.
23. Oliver JA, Barasch J, Yang J, Herzlinger D, Al-Awqati Q. Metanephric mesenchyme contains embryonic renal stem cells. Am J Physiol Renal Physiol 2002;283:799-809.
24. Horster MF, Braun GS, Huber SM. Embryonic renal epithelia: induction, nephrogenesis, and cell differentiation. Physiol Rev 1999;79:1157-91.
25. Kaelin IW. Molecular basis of the VHL hereditary cancer syndrome. Nat Rev 2002;2:673-82.
26. Mitjavila MT, Le Couedic JP, Casadevall N, et al. Autocrine stimulation by serythropoietin and autonomous growth of erythroid leukemic cells in vitro. J Clin Invest 1991;88:789-97.